Navigation Links
Former Thompson lawyer comments on Doyle stem cell executive order

Madison, Wis. - A former chief legal counsel to former Gov. Tommy Thompson said there is nothing inappropriate from a legal standpoint with Gov. Jim Doyle's April 25 executive order on stem cells.

Ray Taffora, a partner in the Madison office of Michael Best & Friedrich, said the governor's powers include the authority to direct state depart......

Full article >>> >
Kanavas has voted with Legislative majorities to enact a comprehensive ban on human cloning, including therapeutic cloning used in research. With therapeutic cloning, an embryo is allowed to develop to the 100 to 200 cell stage, at which point stem cells are isolated for immediate or future use in cell transplantation therapies. The embryo is destroyed in the process of isolating the stem c......

Full article >>> for stem cell products could reach $10 billion over the next ten years, translating into more than 100,000 jobs.

Hamill, however, believes that moral considerations trump economics. "Gov. Doyle now wants us to trust him with inviting 10% of the nation's embryonic stem cell researchers to our state, with no safeguards in place," she said. "The researchers to whom Gov. Doyle has made a ha......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 05/01/06


Related biology technology :

1. Former Fiserv exec to enter Business Hall of Fame
2. Former astronaut a leader in Wisconsin Spaceport
3. Former NSF director to speak at UW-Madison
4. Former Oracle VP reveals thoughts on benefits of IT
5. Former SGI/Cray Team Develops Products for G5 Platform
6. Thompson in partnership to build ethanol plant
7. Tommy Thompsons Iowa strategy isnt far-fetched
8. Tommy Thompson says capital needed for electronic health records
9. Tommy Thompson joins drug company as advisor
10. Tommy Thompson joins Picis board of directors
11. Tommy Thompson will speak at World Congress on IT next May
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... San Diego, CA (PRWEB) , ... June 27, 2016 , ... ... mClinical solutions for clinical trials, announced today the Clinical Reach Virtual Patient ... and their care circle with the physician and clinical trial team. , Using the ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
Breaking Biology Technology:
(Date:6/9/2016)... June 9, 2016 Paris ... Teleste,s video security solution to ensure the safety of people ... during the major tournament Teleste, an international ... and services, announced today that its video security solution will ... to back up public safety across the country. The system ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
Breaking Biology News(10 mins):